Oseltamivir
| Half-life bình thường | carboxylate 6-10 |
|---|---|
| Half-life ESRD | carboxylate >20 |
| Liều bình thường | Treatment: 75 mg po q12h x5 days Prophylaxis: 75 mg po q24h |
| Chỉnh liều suy thận | Treatment: CrCl >60: No dosage adjustment CrCl >30-60: 30 mg q12h x5 days CrCl >10-30: 30 mg q24h x5 days CrCl ≤10, no HD: Not recommended Prophylaxis: CrCl >60: No dosage adjustment CrCl >30-60: 30 mg q24h CrCl >10-30: 30 mg q48h CrCl ≤10, no HD: Not recommended |
| Hemodialysis | Treatment: 30 mg x1, then 30 mg after every HD cycle. Prophylaxis: 30 mg x1, then 30 mg after alternate HD cycles. Pediatrics: For age >1 yr (after each HD): Wt ≤15 kg: 7.5 mg Wt 16-23 kg: 10 mg Wt 24-40 kg: 15 mg Wt >40 kg: 30 mg |
| CAPD | Treatment (CAPD): 30 mg x1. Prophylaxis (CAPD): 30 mg x1, then 30 mg q-week. Treatment (APD): 75 mg po x1 |
| CRRT | No data |
| SLED | No data |